Treatment for oropharyngeal disorders.
Indications
Tantum Verdedol is useful in the symptomatic treatment of irritative-inflammatory conditions also associated with oropharyngeal pain (e.g. gingivitis, stomatitis, pharyngitis).
Composition
Active ingredients: Flurbiprofen.
Excipients: Sucrose, glucose, macrogol, potassium hydroxide, lemon flavoring, levomenthol, honey.
Directions for use and Dosage
Undesirable effects can be minimized by using the lowest effective dose for the highest effective dose. shortest possible duration of treatment necessary to control symptoms.
- Adults and children over 12 years: 1 lozenge to be dissolved slowly in the mouth every 3-6 hours, as needed.
- Elderly people: no dosage changes are necessary.
Do not exceed the dose of 8 lozenges in 24 hours. Do not administer to children under 12 years of age.
Warnings
At the recommended doses, when using the product in its various pharmaceutical forms, any swallowing does not cause any harm to the patient, as the dose of flurbiprofen is much lower than that commonly used in systemic treatments. Use of the product, especially if prolonged, may give rise to sensitization or local irritation; In such cases, treatment should be discontinued and a doctor should be consulted to institute appropriate therapy, if necessary. The product should be used with caution in patients with renal, cardiac, or hepatic insufficiency. It is advisable not to combine the product with other NSAIDs. Cases of bronchospasm have been reported with flurbiprofen in patients with a history of bronchial asthma.
Gastrointestinal Effects: Flurbiprofen should be administered with caution to patients with a history of peptic ulcer and other gastrointestinal diseases, as these conditions may be exacerbated. The risk of gastrointestinal bleeding, ulceration, or perforation is higher with increasing flurbiprofen dosage in patients with a history of ulcer, particularly if complicated by hemorrhage and perforation, and in the elderly. These patients should initiate treatment with the lowest available dose. Gastrointestinal bleeding, ulceration, or perforation has been reported with all NSAIDs at any time during treatment. These adverse events can be fatal and may occur with or without warning symptoms or in the presence of a previous history of serious gastrointestinal events. Patients with a history of gastrointestinal disease, especially when elderly, should report any unusual abdominal symptoms (especially gastrointestinal bleeding) early in the course of treatment. Elderly patients have an increased frequency of adverse reactions to NSAIDs, especially gastrointestinal bleeding and perforation, which may be fatal. Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms.
For further information, carefully consult all information contained in the package leaflet.
Pregnancy and Breastfeeding
During the first and second trimesters of pregnancy, flurbiprofen should not be administered unless clearly necessary. The medicine administered during pregnancy may delay the onset of labor and increase its duration. Flurbiprofen is not recommended for breastfeeding mothers.
Format
16 tablets of 8.75 mg.
Product Code:FRCM118081
Richiedi info sul prodotto
